A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies

Clinical trial NCT03999658 · WITHDRAWN

Trial details

NCT number: NCT03999658
Sponsor: Sorrento Therapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral T Cell Lymphoma Diffuse Large B Cell Lymphoma Biliary Tract Cancer Extranodal NK T Cell Lymphoma, Nasal

Start date: 2023-03-01
Primary completion: 2024-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.